Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors
Clinical trial NCT06027983 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06027983
- Sponsor
- National University Hospital, Singapore
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-01
- Primary completion
- 2026-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.